Project Grant R35GM162369
- Federal Project Grant Award Summary The Ohio State University received a $410,893 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective March 1, 2026, with completion scheduled for December 31, 2030. The award supports research to advance the discovery and biosynthesis of phosphonic acid natural products through genomics-accelerated methodologies. The project aims to establish...
- Federal Project Grant Award Summary The Ohio State University received a $416,726 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 11, 2025, through August 31, 2030. The award funds the development of mass spectrometry-based analytical technologies to enable chemical-specific measurements and proteomic analysis of organoids—three-dimensional cell cultures derived from...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Ohio State University a $597,573 Project Grant on June 1, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct structural and dynamic studies of protein and protein-nucleic acid assemblies relevant to human health and disease. The research employs advanced spectroscopic and microscopic techniques, including multidimensional magic-angle spinning solid-state...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Ohio State University a Project Grant totaling $433,125.00 under the Biomedical Research and Research Training program (CFDA 93.859) to support fundamental research on the molecular consequences of microtubule bending in living cells. The award period extends from August 1, 2025, through June 30, 2030. The research program aims to develop innovative genetically encoded molecular tools that enable...
- Federal Project Grant Award Summary The Ohio State University received a $2.13 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) beginning September 1, 2025, and extending through August 31, 2029. This award supports fundamental research on the developmental regulation of oscillatory gene expression, specifically investigating biological oscillators that control dynamic molecular and...
- Federal Grant Award Summary The Ohio State University received a $408,633 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, through August 31, 2027. This project focuses on developing novel substrate-linked directed evolution (SLIDE) methodology to advance the precision genome editing field by engineering tyrosine family site-specific DNA recombinases...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University a $354,416 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective February 2, 2026, with a completion date of January 31, 2028. This research initiative investigates novel peroxisome functions in Histoplasma capsulatum pathogenesis, specifically examining how the fungal pathogen exploits macrophage organelles to facilitate...
- Grant Award Summary Ohio University received a $460,166 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2028. The award supports research to develop synthetic biology approaches for engineering Lactococcus lactis, a genetically modified bacterium, to synthesize and deliver therapeutic lasso peptides as bioactive natural products. The...
- Federal Grant Award Summary The Ohio State University received a $1.0 million Project Grant from the National Science Foundation (NSF) Division of Emerging Frontiers under the Biological Sciences program (CFDA 47.074), awarded September 1, 2025, with completion targeted for August 31, 2028. The project develops a novel intracellular protein delivery (ICPD) system utilizing an engineered protein called MTD4 to deliver functional proteins directly into native plant tissues for studying...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded The Ohio State University $249,000 on August 22, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the role of host messenger RNA (mRNA) cleavage by ribonuclease L (RNase L) in viral infections. The research project, which extends through July 31, 2028, addresses fundamental gaps in understanding how activated RNase L—triggered by viruses such as...
The Ohio State University received a $375,898 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on March 10, 2026, with a completion date of February 28, 2031. This five-year research project investigates oligosaccharide cross-feeding and competition within microbial communities, specifically examining how human gut bacteria structurally modify dietary polysaccharide intermediates to create nutrient reservoirs that enhance bacterial fitness in competitive environments. The research addresses a significant gap in understanding microbial carbohydrate metabolism by moving beyond traditional pure-culture assays to examine cooperation and competition dynamics in natural microbial communities. The project deliverables encompass three primary research objectives: first, characterizing the structures of modified oligosaccharides produced by gut bacteria to understand how microbial metabolism alters available carbohydrate nutrients; second, establishing how oligosaccharide structures influence bacterial nutrient acquisition and utilization through genetic approaches and synthetic microbial community studies; and third, determining how microbial community composition and host diet shape oligosaccharide availability and utilization. These research activities will generate fundamental knowledge regarding microbial carbohydrate metabolism and inter-bacterial interactions within the human gastrointestinal microbiome, contributing to the NIGMS mission of advancing understanding of biological processes underlying human health.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $375.9k | 3/9/26 |